We conducted a combined genome-wide association study (GWAS) of 7,481 individuals with bipolar disorder (cases) and 9,250 controls as part of the Psychiatric GWAS Consortium. Our replication study tested 34 SNPs in 4,496 independent cases with bipolar disorder and 42,422 independent controls and found that 18 of 34 SNPs had P < 0.05, with 31 of 34 SNPs having signals with the same direction of effect (P = 3.8 × 10 −7 ). An analysis of all 11,974 bipolar disorder cases and 51,792 controls confirmed genome-wide significant evidence of association for CACNA1C and identified a new intronic variant in ODZ4. We identified a pathway comprised of subunits of calcium channels enriched in bipolar disorder association intervals. Finally, a combined GWAS analysis of schizophrenia and bipolar disorder yielded strong association evidence for SNPs in CACNA1C and in the region of NEK4-ITIH1-ITIH3-ITIH4. Our replication results imply that increasing sample sizes in bipolar disorder will confirm many additional loci.
Bipolar disorder is a severe mood disorder affecting more than 1% of the population 1 . Family, twin and adoption studies consistently have found relative risks to first-degree relatives of affected individuals of ~8 and a concordance of ~40-70% for a monozygotic co-twin of affected individuals 1, 2 . Bipolar disorder shares phenotypic similarities with other psychiatric diseases, and relatives of individuals with bipolar disorder are at an increased risk of schizophrenia, major depression and schizoaffective disorder, suggesting a partially shared genetic basis for these disorders 3, 4 . Despite robust evidence for heritability, causal mutations have not been identified through linkage or candidate gene association studies 1 .
GWAS for bipolar disorder have been performed with multiple partially overlapping samples [5] [6] [7] [8] [9] [10] [11] . In a previous small study, researchers reported a genome-wide significant association to DGKH (encoding diacylglycerol kinase eta) 5 . Subsequently, researchers in another study 8 identified the region of ANK3 (encoding ankyrin 3) and those from a third 12 recently reported an association to NCAN (encoding neurocan); other studies did not report genome-wide significant loci 5, 9, 10, 13 . The Psychiatric GWAS Consortium (PGC) was established to facilitate the combination of primary genotype data and to allow analyses both within and across psychiatric disorders 14, 15 . Here, the PGC Bipolar Disorder Working Group reports results from our association study of bipolar disorder from 16,731 samples and a replication sample of 46,918 individuals.
We received primary genotype and phenotype data ( 6, 7, [9] [10] [11] and in combinations 8, 9, 12 in seven publications with case and control overlap. We divided the data into 11 case and control groupings and assigned each individual to only one group ( Table 1) . The final dataset comprised 7,481 unique cases and 9,250 unique controls. Cases had the following diagnoses: bipolar disorder type 1 (n = 6,289; 84%), bipolar disorder type 2 (n = 824; 11%) and schizoaffective disorder bipolar (n = 263; 4%), and there were 105 individuals with other bipolar diagnoses (1%). We directly genotyped 46,234 SNPs in all 11 groups and genotyped 1,016,924 SNPs in between 2 and 11 groups. Based on reference haplotypes from the HapMap phase 2 CEU sample, we imputed missing genotypes using BEAGLE 16 . We analyzed imputed SNP dosages from 2,415,422 autosomal SNPs with a minor allele frequency ≥1% and imputation quality score r 2 > 0.3. We performed logistic regression of case status on imputed SNP dosage including as covariates five multidimensional scaling components (Supplementary Fig. 1 ) and indicator variables for the sample group using PLINK 17 . The genomic control 18 inflation factor (λ GC ) was 1.148. Consistent with previous work suggesting a highly polygenic architecture for schizophrenia and bipolar disorder 19 , this estimate likely reflects a mixture of signals arising from a large number of true risk variants of weak effect and some degree of residual confounding. Nonetheless, we designated an association as genome-wide significant only if the genomic-control P value (P GC ) was below 5 × 10 −8 (the nominal P values are labeled 'P raw '). Results for the primary analyses can be found in Supplementary  Figures 2-4 . Supplementary Table 2 lists regions containing SNPs with P GC < 5 × 10 −5 . Table 2 lists four regions from our primary GWAS analysis that contain SNPs with P raw < 5 × 10 −8 ; two regions reached P GC ≤ 5 × 10 −8 ( Supplementary Fig. 4 ). We detected association in ANK3 (encoding ankyrin 3) on chromosome 10q21 for the imputed SNP rs10994397 (P GC = 7.1 × 10 −9 , odds ratio (OR) = 1.35). The second SNP, rs9371601, was located in SYNE1 (encoding synaptic nuclear envelope protein 1) on chromosome 6q25 (P GC = 4.3 × 10 −8 , OR = 1.15). The intergenic SNP rs7296288 (P GC = 8.4 × 10 −8 , OR = 1.15) is in a region of linkage disequilibrium (LD) of ~100 kb on chromosome 12q13 that contains seven genes. rs12576775 (P GC = 2.1 × Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 9 7 8 VOLUME 43 | NUMBER 10 | OCTOBER 2011 Nature GeNetics l e t t e r s 10 −7 , OR = 1.18) is found at chromosome 11q14 in the first intron of ODZ4, a human homolog of the Drosophila pair-rule gene ten-m (odz). We observed generally consistent signals, with no single study driving the overall association results (Supplementary Fig. 5) . A meta-analysis, under both fixed-and random-effects models, yielded similar results (Supplementary Tables 3 and 4) .
We sought to replicate these findings in independent samples. We selected 38 SNPs with P GC < 5 × 10 −5 (Supplementary Table 2 ). Of these, four SNPs were not completely independent signals, and we did not use these SNPs for further analyses (Online Methods). We received unpublished data from investigators on a further 4,496 cases and 42,422 controls for the top 34 independent SNPs (Supplementary Table 5 ). Significantly more SNPs replicated than would be expected by chance ( Table 3) . Four of 34 SNPs had replication P < 0.01, 18 of 34 SNPs had replication P < 0.05, and 31 of 34 SNPs had a signal in the same direction of effect (binomial test P = 3.8 × 10 −7 ). Within the replication samples, two SNPs remained significant following multiple testing correction. The first SNP, rs4765913, is on chromosome 12 in CACNA1C, which encodes the α subunit of the L-type voltage-gated calcium channel (replication P = 1.6 × 10 −4 , OR = 1.13). The second SNP, rs10896135, is in a 17-exon 98-kb open reading frame of C11orf80 (replication P = 0.0015, OR = 0.91), and variants in several other genes are in strong linkage disequilibrium with this SNP. We obtained nominally significant replication P values in another gene encoding a calcium channel subunit, CACNB3 (replication P = 0.0025, OR = 0.93). Only two of the four SNPs listed in Table 2 had replication P < 0.05; the genome-wide significant SNPs rs10994397 and rs9371601 did not have P < 0.05 (replication P = 0.12 and P = 0.10, respectively). Finally, we performed a fixedeffects meta-analysis on our effect estimates from the primary and replication data and established genome-wide significant evidence for association with rs4765913 in CACNA1C (P = 1.52 × 10 −8 , OR = 1.14) and rs12576775 in ODZ4 (P = 4.40 × 10 −8 , OR = 0.89) (Fig. 1) . As in the primary analyses, we observed consistent signals, and a meta-analysis of the replication data did not reveal significant heterogeneity between the samples (Supplementary Tables 6 and 7) .
To interpret why two significant associations found in the primary analysis fail to replicate, we quantified the effect of the 'winner's curse' . Given a polygenic model, power will be low to detect a particular variant at genome-wide significant levels, but there will be many chance opportunities to identify at least one variant. Simulation of the distribution of ORs around several 'true' ORs, conditioning on a genome-wide significant P value of 5 × 10 −8 , a fixed minor allele frequency of 0.20 and our sample size showed a distinct inflation of the estimated OR, leading to a marked overestimate of the power to replicate an individual result (Supplementary Table 8 ). For example, for a true genotypic relative risk of 1.05, the mean estimated OR is 1.17 conditioning on P < 5 × 10 −8 . Although the nominal power for replication is 100% for the inflated OR, the true power to replicate at P < 0.05 is only 30%. Thus, any single replication failure is by itself less informative. This simulation is consistent with our observations of higher than expected rate of nominal replications.
We assessed enrichment of Gene Ontology (GO) terms for regions containing the top 34 independent SNPs listed in Table 3 (P GC < 5 × 10 −5 ) using a permutation-based approach that controlled for potential biases caused by SNP density, gene density and gene size and found enrichment in GO:0015270, the category containing voltage gated calcium channel activity. This GO category contains eight genes, three of which (CACNA1C, CACNA1D and CACNB3) are present among the 34 independent association intervals tested (P = 0.00002); the probability of observing an empirical P value this small, given all the targets tested, is P = 0.021. Thus, intervals ranked highly in our GWAS likely do not represent a random set with respect to gene function. Studies based on a larger number of loci, defined by more liberal P-value cutoffs, could indicate other promising areas for biological investigation. 
l e t t e r s
We performed a conditional analysis that included the 34 independent SNPs listed in Table 3 . We identified SNPs within 1 Mb of the most associated SNP that continued to show evidence of association (conditional P GC < 10 −4 ) in three regions. A region-specific conditional analysis showed conditional association at 3p21.1 (rs736408, conditional P GC = 8.1 × 10 −7 ), 10q21.2 (rs9804190, conditional P GC = 7.3 × 10 −5 ) and 15q14 (rs16966413, conditional P GC = 7.3 × 10 −5 ) (Supplementary Fig. 6 ). On chromosomes 3 and 15, the SNP most strongly associated after conditioning was >500 kb from the conditioning SNP, and multiple genes are present in the intervening interval. On chromosome 10, we observed additional less strongly associated conditionally independent SNPs located upstream of the l e t t e r s 5′ end of ANK3, in an intron of ANK3 and at the 3′ end of the longest transcript (705 kb in length). In each of these three regions, the association signals remaining after conditioning could arise from multiple causal variants, from a single rare causal variant in incomplete LD with the tested SNPs or could represent false-positive associations.
To provide direct evidence for a polygenic basis for bipolar disorder-as implied by the polygenic component shared between bipolar disorder and schizophrenia previously reported 19 -we repeated the analysis performed by the International Schizophrenia Consortium using bipolar disorder discovery samples. We observed enrichment of putatively associated bipolar disorder 'score alleles' in target sample cases compared to controls for all discovery P value thresholds (Supplementary Table 9) .
A parallel study was performed by PGC schizophrenia investigators. We tested whether a combined analysis of PGC bipolar disorder and PGC schizophrenia data (eliminating known overlapping control samples) would show stronger association for the five most strongly associated SNPs supplemented by the additional genome-wide significant replication region in CACNA1C. In the combined bipolar disorder and schizophrenia analysis, two SNPs showed stronger association compared to the bipolar disorder GWAS alone: rs4765913 in CACNA1C (combined P raw = 7.7 × 10 −8 compared to bipolar disorder P raw = 1.35 × 10 −6 ) and rs736408 in a multigene region containing NEK4-ITIH1-ITIH3-ITIH4 (combined P raw = 8.4 × 10 −9 compared to bipolar disorder P raw = 2.00 × 10 −7 ) (Supplementary Table 10 ).
In summary, we observed primary association signals that reached genome-wide significance in the regions of ANK3 and SYNE1 and two signals near genome-wide significance on chromosome 12 and in the region of ODZ4. Although in our independent replication sample we did not find additional support for ANK3 or SYNE1, this is consistent with overestimation of the original ORs and should not be taken to disprove association. Data from additional samples are needed to resolve this.
The most notable finding is the abundance of replication signals. The number of nominal associations in the same direction of effect is highly unlikely to be a chance observation and strongly implies that many of the signals will ultimately turn out to be true associations. Such results are expected under a highly polygenic model, where there are few or no variants of large effect. As is typical in studies of complex genetic disorders, our findings explain only a small fraction of bipolar disorder heritability. Our data are consistent with many common susceptibility variants of relatively weak effect 19 potentially operating together with rarer variants 20 . Although this was the largest GWAS study of bipolar disorder to date, our sample size remains modest compared to other recent studies and is therefore likely underpowered. Subject ascertainment, assessment and population variation could also potentially reduce power to detect loci with relatively specific phenotypic effects.
A pathway analysis showed significant enrichment of CACNA1C and CACNA1D, which encode the major L-type α subunits found in the brain, consistent with a prior literature regarding the role of ion channels in bipolar disorder, the mood stabilizing effects of ion channel modulating drugs and the specific treatment literature suggesting direct efficacy of L-type calcium channel blockers in the treatment of bipolar disorder 21 . The CACNA1C SNP rs1006737 has been associated with several alterations in structural 22 and functional magnetic resonance imaging [23] [24] [25] . Several groups have previously implicated CACNA1C in other adult psychiatric disorders, in particular, schizophrenia and major depression [26] [27] [28] [29] . L-type calcium channels regulate changes in gene regulation responsible for many aspects of neuronal plasticity and may have direct effects on transcription 29 . Taken together, this should lead to renewed biological investigation of calcium channels in psychiatric disease. ODZ4, located on chromosome 11, encodes a member of a family of cell surface proteins, the teneurins, and is related to the Drosophila pairrule gene ten-m (odz). These genes are likely involved in cell surface signaling and neuronal pathfinding.
Three of our top five regions harbor non-coding RNAs. miR-708, a member of a conserved mammalian microRNA family, is located in the first intron of ODZ4. Three small nucleolar RNAs (snoRNAs), SNORD69, SNORD19 and SNORD19B, are located on chromosome 3p21.1 and belong to the C/D family of snoRNAs. Finally, a 121-base non-coding RNA with homology to 5S-ribosomal RNA is within the SYNE1 association region. The role of microRNAs and non-coding RNAs in neurodevelopmental disorders is increasingly apparent in Rett's syndrome, fragile X syndrome and schizophrenia. Our study represents, to our knowledge, the first connection of these regions to bipolar disorder.
In conclusion, we obtained strong evidence for replication of multiple signals in bipolar disorder. In particular, we support prior findings in CACNA1C and now identify an intronic variant in ODZ4 as being associated with bipolar disorder. These replication results imply that data from additional samples, both from GWAS and sequencing, will identify more of the genetic architecture of bipolar disorder. Finally, our combined analysis with schizophrenia illuminates the growing appreciation of the shared genetic epidemiology of these two disorders 30 and the shared polygenic contribution to risk 19 . 
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Sample description. These analyses used bipolar disorder case-control GWAS data from international collections ('primary studies'). Sample ascertainment details are provided in prior publications (Table 1 ) and the Supplementary Note. Standardized semi-structured interviews were used to collect clinical information about lifetime history of psychiatric illness, and operational criteria were applied to make lifetime diagnoses. All cases have experienced pathologically relevant episodes of elevated mood (mania or hypomania) and meet the criteria for bipolar disorder within the primary study classification system. Controls were selected from the same geographical and ethnic populations as the cases and had a low probability of having bipolar disorder. Some control selection criteria excluded individuals with a personal history of mood disorder, and other controls were unscreened. The distribution of diagnoses is shown in Supplementary Table 1 . Protocols and assessment procedures were approved by the institutional review boards of the authors' institutions. All participants provided written informed consent, and consent allowed the samples to be used within the current analyses.
PGC central data quality control pipeline. Primary study genotype data were deposited on the Genetic Cluster Computer (see URLs) hosted by the Dutch National Computing and Networking Services. Data were generated using four different genotyping platforms (Affymetrix 500K, 5.0, 6.0 and Illumina HumanHap 500). Data were processed by the PGC central analysis committee pipeline, which performed semi-automated formatting, quality testing, inter-and intra-study relatedness checks and imputation. First, SNP names, positions and strand were harmonized. For SNPs with <5% missing data, individuals were retained if the missing genotype rate per individual was <0.02. Subsequently, SNPs were retained if the missing genotype rate per SNP was <0.02, the missing genotype rate between cases and controls per SNP was <0.02 (absolute difference), Hardy-Weinberg equilibrium (controls) P > 1 × 10 −6 and the frequency difference to the HapMap reference was <0.15. This removed 380,959 SNPs and 177 individuals from the 11 bipolar disorder studies. After these steps, there were 10,926 controls and 8,338 cases for analysis. Data were imputed using BEAGLE 3.0 (ref. 16) , with phased HapMap phase 2 data as a reference. Each dataset was imputed separately, splitting into imputation batches of 300 individuals randomly, keeping the case-control ratio balanced.
Duplicate sample elimination. Using PLINK 17 , we found that 3,714 individuals in 2,316 pairs were duplicated, which we defined as a pair of samples with an estimated probability of genome-wide identity-by-descent of sharing two chromosomes above 90%. To remove duplicates, in order to preserve case:control ratios as close to 50:50 as possible and to favor data generated using more recent platforms, we preferentially kept samples from duplicate pairs in the order as follows: BOMA-bipolar study, TOP, STEP2, NIMH/PRITZKER, GAIN/BiGS, STEP1, TRINITY COLLEGE, UEDINBURGH, GSK, UCL and then WTCCC. The final dataset contained only unique individuals, with each individual belonging to exactly one sample. We further detected instances of previously unknown close relatedness. After removing a small number of parent-offspring, full-sibling and half-sibling pairs, we were left with N = 16,731 individuals in 16,254 families (including 477 known sibling pairs from NIMH/PRITZKER).
Ancestry evaluation. We used the WTCCC control sample to select SNPs in approximate linkage equilibrium to calculate multi-dimensional scaling (MDS) components to assess and correct for population stratification. This yielded N = 21,134 autosomal SNPs, genotyped on all platforms, which is sufficient for this MDS analysis. We calculated the top 20 MDS components. Based on inspection of between-and within-sample correlation with the phenotype, we retained the top five components, which were used as covariates along with ten binary dummy variables to control for differences between the 11 samples (Supplementary Fig. 1 ).
Association analyses. Primary analyses. Following initial quality control and elimination of duplicates, there were 16,731 individuals and 2,541,952 SNPs. Analyses are based on the 2,415,422 SNPs with minor allele frequency >1% and imputation r 2 > 0.3 with a HapMap SNP. The primary analysis was a logistic regression of disease state on single-SNP allele dosage including covariates to account for site as well as the first five quantitative indices of ancestry based on the MDS analyses. To adjust for the relatedness between the siblings, we used a robust Huber-White sandwich variance estimator for cluster-correlated observations. All association analyses were performed using PLINK v1.07 (ref. 17) with no clinical covariates. The genomic inflation factor (λ) was calculated as the ratio between the observed and expected median χ 2 statistics, was 1.148 and was used to correct for the degree of inflation (Supplementary Fig. 2 ). The LD-based associated regions with P < 5 × 10 −5 presented in Supplementary  Table 2 were based on the clumping approach (PLINK). Specifically, we took all SNPs significant at P < 5 × 10 −5 that had not already been clumped (denoting these as index SNPs) and formed clumps of all other SNPs that are within 1 Mb of the index SNP, in LD with the index SNP (r 2 > 0.2) or nominally associated with disease (P < 0.05). This approach grouped SNPs in LD space rather than physical distance. This clumping approach resulted in 38 SNPs with P < 5 × 10 −5 .
Replication analyses. From each replication sample, we obtained information on P values, ORs, standard errors (SE), minor allele frequencies and the associated risk allele for SNPs listed in Supplementary Table 2 . If the target SNP listed in Supplementary Table 2 was not present in the replication dataset, we obtained a proxy SNP in strong LD and weighted the SE to account for the lack of information: SEW = SE/sqrt(r 2 ). The estimate (ES), β, is the natural logarithm of the odds ratio. We performed a standard meta-analysis to estimate a common odds ratio weighted by individual study's SE (Supplementary Table 8 
SE i
We combined the odds ratios and standard errors from the discovery and replication samples using a fixed effect meta-analysis. The final P values are genomic-control adjusted based on a λ of 1.176, estimated from all available GWAS data (from both wave 1 and the replication samples).
Gene Ontology (GO) enrichment analyses. We looked for terms enriched for genes in the most associated intervals. We started with the 38 intervals described above. Only 34 regions were analyzed by collapsing any regions that (i) physically overlapped, (ii) spanned the same gene or (iii) did not show conditionally independent association signals. Three regions contain SNPs that had low pairwise r 2 but did not show independent association when covarying for the neighboring SNP, reflecting high LD measured in terms of D′ and not indicative of truly independent signals. The enrichment analysis depended on the assumption of independence between intervals so as not to double count genes. The final list contained 34 independent regions. We used NCBI gene2go (see URLs) and mapped Entrez GeneIDs to gene symbols and hg18 coordinates using the UCSC Genome Browser. Of the 9,834 total GO terms, we restricted the analysis to terms with at least 2 and not more than 200 human genes, leaving 6,482 GO terms ('targets'). For each target, we counted the number of association intervals that contained at least one target gene; we required that at least two intervals contained at least one gene from each target. We evaluated the probability of observing the number of intersecting intervals by chance alone using a permutation procedure (implemented in INRICH software (see URLs)). Specifically, we randomly placed each independent interval in an alternate position on the genome matching for the total number of SNPs and implied new size of the interval (the distance in bp was within a factor of 0.8-1.2 of the original) and the total number of genes. In this manner, we controlled for potential biases caused by SNP and gene density and gene size. We repeated the permutation 100,000 times and corrected for multiple testing by evaluating the distribution of minimum empirical P values under the null hypothesis given 6,482 tested targets. The corrected empirical P values implicitly account for the non-independence of the GO terms.
Conditional analyses.
To identify additional signals after accounting for the effects of the initial GWAS signals, we performed a conditional analysis including the most strongly associated SNPs in the analysis of each SNP. In regions in which we detected a potential secondary signal(s) (P GC < 10 −4 ), we performed separate conditional analyses using the initial GWAS-identified
